JP2021101270A - Medicine information registration support program, medicine information registration support system, and medicine information registration support method - Google Patents

Abstract

To enable exclusion medicine to be easily set when registering medicine information in a database.SOLUTION: A medicine information registration support program causes a computer to execute: a process in which according to reception of a first registration indication including setting information that includes set values relating to comprehensive processing in medical operation account processing of an intended medicine that is the object of medical operation account processing, a storage area is referred to, the storage area being stored with exclusion medicine not object of comprehensive account processing and being registered with information on the exclusion medicine not object of medical account processing, and picture information 260 inquiring whether the intended medicine is registered in the exclusion medicine database is output when the setting information included in the first registration indication is different from the initial setting information of the intended medicine; and a process in which the intended medicine in the exclusion medicine database is registered when a second registration indication indicating that the intended medicine registered in the exclusion medicine database is received.SELECTED DRAWING: Figure 13

Description

The present invention relates to a drug information registration support program, a drug information registration support system, and a drug information registration support method.

Medical accounting that manages information on drugs (“drugs”, “drugs”, or may simply be called “drugs”) and uses them for medical services (medical affairs) such as prescribing and accounting for drugs to patients. The system is known.

By the way, the cost of administering the drug to hospitalized patients is the daily score of the specific hospitalization fee and the daily score for each DPC diagnosis group classification (hereinafter referred to as "comprehensive evaluation score"). In principle, the cost cannot be calculated individually and charged to the patient.

The specific hospitalization fee is a method of evaluating medical expenses based on the ward, ward, specific disease, etc., and the DPC is used for a flat-rate payment system for medical expenses per day of hospitalization, which is called the diagnosis group classification comprehensive evaluation. Diagnosis Procedure Combination.

However, for some drugs, such as expensive drugs, from a cost perspective, as an exception, it is permitted to individually calculate the cost of administering the drug to the inpatient and charge the patient. There is. Hereinafter, some of such drugs, that is, drugs that are not subject to comprehensive treatment at the time of accounting treatment, will be referred to as “excluded drugs” or “excluded drugs”.

The main types of excluded drugs are described in, for example, "Appendix 5-1-2" of "Ministry of Health, Labor and Welfare Notification No. 44 Basic Medical Fee Facility Standards, etc." dated March 5, 2018. As described above, the following types can be mentioned.

-Interferon preparation (limited to those having the indication or effect of hepatitis B or hepatitis C)
-Antiviral agents (limited to those having the indication or effect of hepatitis B or hepatitis C and those having the indication or effect of acquired immunodeficiency syndrome or HIV infection)
・ Blood coagulation factor preparations and blood coagulation factor antibody bypass activity complex for the treatment of hemophilia

In the medical accounting system, a method of calculating the volume of excluded drugs may be adopted by setting the target or non-target of comprehensive evaluation based on DPC for each drug.

Japanese Unexamined Patent Publication No. 2007-188342 Japanese Unexamined Patent Publication No. 2001-76062 Japanese Unexamined Patent Publication No. 2016-164746

However, the specific items and ingredients of the excluded drug may not be specified in the notification or notification that regulates the excluded drug. For this reason, it may be difficult to accurately determine (specify) the specific items and ingredients of the excluded drug notified or notified unless the hospital staff has medical and pharmaceutical knowledge.

In addition, even hospital staff with medical and pharmaceutical knowledge take a lot of time to investigate the setting of excluded drugs in the medical accounting system, and setting mistakes are likely to occur. For example, if a mistake in setting an excluded drug occurs, there is a possibility that the calculation of the excluded drug and the omission of billing may occur. Such calculation of excluded drugs and omission of claims have a great influence on the profits of hospitals, and can be one of the factors that put pressure on management.

In one aspect, one of the objects of the present invention is to facilitate setting of excluded drugs when registering drug information in a database.

In one aspect, the drug information registration support program may cause the computer to perform the following processes: The processing is performed during the medical accounting process in response to the reception of the first registration instruction including the setting information including the setting values related to the comprehensive processing at the time of the medical accounting processing of the first target drug subject to the medical accounting processing. The setting information included in the first registration instruction is the initial setting information of the first target drug by referring to the storage area for storing the exclusion drug database in which the information about the excluded drug that is not subject to the comprehensive processing of is registered. If it is different from the above, the first screen information asking whether or not to register the first target drug in the excluded drug database may be output. The process may register the first target drug in the exclusion drug database when it receives a second registration instruction instructing the first target drug to be registered in the exclusion drug database.

In one aspect, when registering drug information in a database, settings related to excluded drugs can be easily executed.

It is a block diagram which shows the functional structure example of the drug information registration system which concerns on one Embodiment. It is a figure which shows an example of the in-hospital adopted drug master. It is a figure which shows an example of the standard setting value master. It is a figure which shows an example of the in-hospital adopted drug master registration change screen. It is a figure which shows an example of the exclusion drug comprehensive setting table. It is a figure which shows an example of the drug price standard listed drug code. It is a figure which shows an example of an individual drug code. It is a flowchart for demonstrating the operation example of the drug information registration system which concerns on one Embodiment. It is a flowchart for demonstrating the operation example of the drug information registration system which concerns on one Embodiment. It is a figure which shows an example of a warning message. It is a figure which shows an example of the in-hospital adopted drug master registration change screen. It is a figure which shows an example of a warning message. It is a figure which shows an example of a warning message. It is a block diagram which shows the hardware configuration example of the computer which concerns on one Embodiment.

Hereinafter, embodiments of the present invention will be described with reference to the drawings. However, the embodiments described below are merely examples, and there is no intention of excluding the application of various modifications or techniques not specified below. For example, the present embodiment can be variously modified and implemented without departing from the spirit of the present embodiment. In the drawings used in the following description, the parts having the same reference numerals represent the same or similar parts unless otherwise specified.

[1] Embodiment [1-1] Functional configuration example of drug information registration system FIG. 1 is a block diagram showing a functional configuration example of the drug information registration system 1 according to one embodiment. The drug information registration system 1 is an example of a drug information registration support system that supports the registration of drug information, and may be positioned as a system that focuses on the drug information management function included in the medical accounting system. The drug information registration system 1 (or medical accounting system) may be used in an organization, for example, a medical institution such as a hospital or a clinic.

As illustrated in FIG. 1, the drug information registration system 1 may optionally include a server 2 and one or more operation terminals 3 (plural in FIG. 1).

The operation terminal 3 is a computer such as a PC (Personal Computer) or a server used by an employee of an organization, for example, an employee of a medical institution in the drug information registration system 1, and is an example of an information processing terminal used by the user.

Each operation terminal 3 accesses the server 2 such as registration or change (may be referred to as "correction" or "update") of drug information. The access may include a reference. The server 2 and the operation terminal 3 may be connected to each other so as to be able to communicate with each other via a network (not shown). The network may include a WAN (Wide Area Network), a LAN (Local Area Network), or a combination thereof. The WAN may include the Internet and the LAN may include a VPN (Virtual Private Network).

The server 2 is an example of a drug information registration support device, an information processing device, or a computer that manages registration, change, reference, and the like of drug information in the drug information registration system 1. The server 2 may execute processing such as registration, change, or reference of drug information according to the access by the operation terminal 3, and send a response to the operation terminal 3. For example, the server 2 may provide a function for enabling access by the operation terminal 3. Examples of the function include generation and display control of a screen such as a web page used for access by the operation terminal 3. For example, the operation terminal 3 may access the server 2 using an application such as a browser and access the server 2 via a web page.

The server 2 may be a virtual server (VM: Virtual Machine) or a physical server. Further, the function of the server 2 may be realized by one computer or may be realized by two or more computers. Further, at least a part of the functions of the server 2 may be realized by using the HW (Hardware) resource and the NW (Network) resource provided by the cloud environment.

As shown in FIG. 1, the server 2 may optionally include a memory unit 21, a communication unit 22, a processing unit 23, and a screen control unit 24 as functional configurations.

The memory unit 21 is an example of a storage area, and stores various information used for managing drug information. As shown in FIG. 1, the memory unit 21 may optionally store the in-hospital adopted drug master 21a, the standard set value master 21b, and the excluded drug comprehensive setting table 21c. In the following description, the data formats of the information 21a to 21c are each set to a table format, but the present invention is not limited to this. The data format of the information 21a to 21c may be various formats such as DB (Database) or an array.

The in-hospital adopted drug master 21a is master data of drug information managed by a medical accounting system, for example, a drug information registration system 1, and is an example of a drug database. The in-hospital drug master 21a is individually set (user setting) according to the medical institution. When the server 2 receives the access to the drug information from the operation terminal 3, the server 2 may refer to the in-hospital adopted drug master 21a and perform the processing related to the access.

FIG. 2 is a diagram showing an example of the in-hospital adopted drug master 21a. As shown in FIG. 2, the in-hospital drug master 21a may optionally include items such as the official name of the drug, the drug code, and the value of the comprehensive category. An entry containing the official name of the drug, the drug code, and the value of the comprehensive category is an example of drug information.

The official name of the drug is the official name of the drug, and may be, for example, the common name of the item listed under the unified name or the individual product name of the item listed under the unified name. A unified name listed item is a generic name item listed in the official bulletin. The official name of the drug may include a standard unit (1 tablet of 5 mg (milligram) in the example of FIG. 2), and may include a company name (manufacturer name) in the case of individual product names.

The drug code is a code given to a drug and is an example of identification information of a target drug subject to medical accounting processing. The drug code may be, for example, one or both of the drug price standard listed drug code and the individual drug code (which may be referred to as “YJ code”).

The drug price standard listed drug code is a 12-digit alphanumeric code set in the drug price unit. According to the rules for assigning drug code listed on the drug price standard, one code is assigned to the generic name of the item listed under the unified name. In the drug price standard listed drug code, the same code is given even if there are multiple products with the same generic name for the items listed under the unified name.

The individual drug code is a 12-digit alphanumeric code. In the rules for assigning individual drug codes, separate codes are assigned to individual products of items listed under the unified name.

The value of the comprehensive category is an item in which various values related to the excluded drug are set. Excluded drugs are some drugs, such as expensive drugs, as described above, and it is permitted to individually calculate the cost of administering the drug to the inpatient and charge the patient. It is a drug.

The value of the inclusion category may include setting values of a plurality of items as individual elements. In the example of FIG. 2, the "item" may be an element for which a value is individually set, such as "specific intensive care", "newborn", "emergency emergency", ..., "Comprehensive category N", etc. .. As described above, the value of the comprehensive category is an example of the setting information including the setting value related to the comprehensive processing at the time of medical accounting processing of the target drug. In the following description, when the entire value of the comprehensive category is described as "comprehensive category setting information" and each item of the comprehensive category value is described as "comprehensive category setting value" or simply "set value". There is.

The standard set value master (hereinafter, may be referred to as “standard master”) 21b is default master data provided by a vendor of a medical accounting system, for example, a drug information registration system 1, and is an example of a reference drug database. Is.

FIG. 3 is a diagram showing an example of the standard master 21b. As shown in FIG. 3, the standard master 21b may have the same data structure as the in-hospital drug master 21a.

The standard master 21b may include drug information about all drugs available to the medical institution. For example, when an update such as addition of a new drug or abolition of an existing drug occurs, the vendor may provide the updated standard master 21b.

In the comprehensive classification setting information of the standard master 21b, all comprehensive classification setting values may be set to initial values (default values). The “initial value” is a standard (reference) set value set by the vendor in the standard master 21b. As an example, the initial values of the comprehensive classification set values may be all "0". The initial value is not limited to "0", and a value other than "0" may be set for each drug and for each item in the comprehensive category at the discretion of the vendor.

In the following description, it is assumed that the initial values of all the comprehensive classification setting values are "0". For example, when the comprehensive classification setting value is the initial value (0), the item is subject to comprehensive processing. Therefore, when all the comprehensive category setting values of the comprehensive category setting information are initial values, the drug is a non-excluded drug (ordinary drug) subject to comprehensive processing in the medical accounting process. As described above, the comprehensive classification setting information (initial comprehensive classification setting information) registered in the standard master 21b is an example of the initial setting information including the initial value related to the comprehensive processing at the time of medical accounting processing of the target drug.

For example, the in-hospital adopted drug master 21a may be created or updated based on the standard master 21b at the time of initial setting of the drug information registration system 1, update of the standard master 21b, or the like. As an example, a medical institution employee or a vendor worker duplicates the necessary data in the master data of the standard master 21b and registers or adds it to the in-hospital drug master 21a to register or add the in-hospital drug master. 21a may be created or updated.

For example, if at least one comprehensive category setting value among the drug information registered in the in-hospital adopted drug master 21a is a value other than the initial value (value different from the initial value), the drug is subjected to medical accounting processing. It is an excluded drug that is not subject to comprehensive treatment. Therefore, when registering an excluded drug in the in-hospital adopted drug master 21a, the staff of the medical institution sets at least one comprehensive category setting value other than the initial value (for example, 0) in the comprehensive category setting information of the excluded drug. You can set it.

The staff of the medical institution may limit the drug information registered in the in-hospital drug master 21a from the standard master 21b to the drug information of the drug to be handled in the medical institution (in-hospital). In addition, the staff of the medical institution may create and update the in-hospital drug master 21a according to the standards (rules) of the medical institution, etc., regardless of the standard master 21b.

Returning to the description of FIG. 1, the communication unit 22 performs access-related communication between the server 2 and the operation terminal 3. For example, the communication unit 22 transmits the screen information of the web page generated or updated by the screen control unit 24 to the operation terminal 3 in response to the reception of the access request from the operation terminal 3. The access request may include operation contents on a web page by the operation terminal 3, for example, control information for registering, changing, or referring to drug information. The communication unit 22 realizes the access to the server 2 by the operation terminal 3 by repeating the reception of the access request and the transmission of the screen information.

The access request for registering drug information (for example, new registration) to the server 2 transmitted from the operation terminal 3 is an example of the first registration instruction, and is an example of the first target drug subject to medical accounting processing. It may include setting information including setting values related to comprehensive processing in medical accounting processing. The access request may include identification information of the first target drug.

The processing unit 23 performs various processes on the information stored in the memory unit 21 based on the access request received from the operation terminal 3 by the communication unit 22.

The screen control unit 24 generates or updates the screen information of the web page based on one or both of the access request received from the operation terminal 3 by the communication unit 22 and the processing result by the processing unit 23.

The screen control unit 24 generates the screen information of the in-hospital adopted drug master registration change screen 200 in response to the reception of the access request from the operation terminal 3, for example, the reception of the access request related to the registration or update of the drug information to the server 2. Then, it is output to the communication unit 22.

FIG. 4 is a diagram showing an example of the in-hospital adopted drug master registration change screen 200. As shown in FIG. 4, the in-hospital drug master registration change screen 200 exemplifies, for example, the drug official name setting area 210, the drug price setting area 220, the drug code setting area 230, and the comprehensive classification setting information. The setting area 240 may be displayable.

The formal name setting area 210 of the drug is an area for inputting the formal name of the drug. Even if the official name of the drug information searched by the processing unit 23 from the in-hospital adopted drug master 21a or the standard master 21b based on the code input to the setting area 230 of the drug code is displayed in the setting area 210. Good.

The drug price setting area 220 is an area where the drug price is input or displayed. The drug price is the official price of the drug. The drug code setting area 230 is an area in which the drug code of the drug to be registered or changed in the in-hospital drug master 21a is input or displayed. As described above, the drug code may be a drug price standard listed drug code or an individual drug code, and in one embodiment, it shall be an individual drug code. The setting area 240 of the comprehensive classification setting information is an area in which the comprehensive classification setting value of the drug is input or displayed for each item.

[1-2] Description of Processing Unit Next, the details of the processing unit 23 of the server 2 will be described. The processing unit 23 registers the drug information in the in-hospital adopted drug master 21a based on the access request including the operation content to the in-hospital adopted drug master registration change screen 200. In the following description, "registration" shall include both the meaning of "addition" of a new entry and "change (update)" of an existing entry.

In addition, the processing unit 23 according to one embodiment is appropriately related to the excluded drug with respect to the drug information to be registered or changed based on the excluded drug comprehensive setting table (hereinafter, may be referred to as “excluded table”) 21c. The screen control unit 24 controls the display of various alerts.

Therefore, as illustrated in FIG. 1, the processing unit 23 may have the functions of the master management unit 23a, the exclusion table management unit 23b, and the determination unit 23c.

The master management unit 23a is an example of the second registration unit, and is excluded from the in-hospital adopted drug master 21a according to one or both of the access request received from the operation terminal 3 and the determination result by the determination unit 23c described later. The drug information of the drug may be registered.

The exclusion table management unit 23b is an example of the first registration unit, and when the master management unit 23a registers the drug information of the excluded drug in the in-hospital adopted drug master 21a as the in-hospital adopted drug, the exclusion table 21c is excluded from the exclusion table 21c. The drug information of the drug may be registered. For example, the exclusion table management unit 23b stores information on the components of the drug in the exclusion table 21c, using at least a part of the drug code of the drug set as the exclusion drug as a key.

By management by the exclusion table management unit 23b, the exclusion table 21c accumulates information on excluded drugs that are not subject to comprehensive processing during medical accounting processing, among the drug information registered in the in-hospital adopted drug master 21a. Will be done.

FIG. 5 is a diagram showing an example of the exclusion table 21c. As shown in FIG. 5, the exclusion table 21c is an example of an exclusion drug database in which information on exclusion drugs that are not subject to comprehensive processing in medical accounting processing is registered. Items such as the value of the comprehensive category (comprehensive category setting information) may be included.

The comprehensive category setting information is an example of information on the excluded drug, and various values related to the excluded drug may be set. Comprehensive classification setting information is an example of setting information including setting values related to comprehensive processing at the time of medical accounting processing of excluded drugs. In the comprehensive classification setting information of the exclusion table 21c, for example, the presence / absence and setting of the comprehensive setting unique to the medical institution for the drug set so that it can be calculated separately from the daily score of the specific hospitalization fee and the comprehensive evaluation score. It can be said that the value is set.

For example, in the comprehensive classification setting information of the exclusion table 21c, the following, depending on the match or disagreement between the comprehensive classification setting value of the in-hospital adopted drug master 21a and the comprehensive classification setting value of the standard setting value master 21b, for each item May be set as.

When the comprehensive category setting value is different between the standard set value master 21b and the in-hospital adopted drug master 21a, the exclusion table management unit 23b sets the comprehensive category setting value in the exclusion table 21c to the in-hospital adopted drug master 21a. Set the comprehensive classification setting value.

-When the comprehensive category setting value is the same between the standard set value master 21b and the in-hospital drug master 21a, the exclusion table management unit 23b matches the comprehensive category setting value in the exclusion table 21c. Set a value indicating (same), for example, "0". In one embodiment, the initial value of the standard master 21b is "0". Therefore, the item in which the comprehensive classification setting value of the exclusion table 21c is "0" can be regarded as an initial value.

The drug code registered in the exclusion table 21c is an example of a character string of a part of the identification information of the excluded drug. In the drug code of the exclusion table 21c, a partial code of the drug price standard listed drug code or the individual drug code of the drug set as the excluded drug may be set as a key. In one embodiment, the drug code in the exclusion table 21c is set to the upper 7-digit code (character string) of the drug price standard listed drug code or the individual drug code.

FIG. 6 is a diagram showing an example of a drug price standard listed drug code, and shows “2456001F1019” which is a drug price standard listed drug code of “prednisolone tablet (5 mg 1 tablet)”.

As shown in FIG. 6, the drug price standard listed drug code is a code obtained by concatenating a plurality of codes in which one or more consecutive digits are combined. As for the drug price standard listed drug code, for example, assuming that the highest digit (left end in FIG. 6) is the 0th digit and the lowest digit (right end in FIG. 6) is the 11th digit, the following codes A to F It is a code that concatenates.

-Code A (0th to 3rd digits): Drug efficacy classification number-Code B (4th to 6th digits): Route of administration and ingredients (internal medicine: 001 to 399, injectable medicine: 400 to 699, external medicine: 700 to 999)
-Code C (7th digit): Dosage form (In the case of oral medicine, powder: A to E, tablets: FL, capsules: MP, liquid: Q to S,
Others: T, X)
-Code D (8th digit): Number for each standard unit within the same classification according to the above codes A to C-Code E (9th and 10th digits): Number for each brand within the same standard according to the above code D-Code F (11th digit): Check digit (number for checking the reading error of the previous 11 digits (0th to 10th digits))

Based on such a code system, the prednisolone tablets (5 mg, 1 tablet) illustrated in FIG. 6 have the following characteristics based on the values of the 0th to 8th digits (upper 9 digits: codes A to D) surrounded by the alternate long and short dash line. Is identified as a drug with. That is, the prednisolone tablet (5 mg, 1 tablet) is a tablet having a medicinal effect classified by "2456" and having an administration route and an ingredient classified by "001" (oral drug), and is a standard specified by "1". It is a unit and a brand specified by "01".

FIG. 7 is a diagram showing an example of an individual drug code, and shows a product containing "prednisolone tablets" as an ingredient.

As shown in FIG. 7, the individual drug code is a code in which a plurality of codes in which consecutive one or more digits are combined are concatenated. Assuming that the most significant (leftmost in FIG. 7) digit is the 0th digit and the lowest (rightmost in FIG. 7) digit is the 11th digit, the 0th to 8th digits of the individual drug code (codes A to D) (Equivalent) is a code indicating the drug efficacy classification number, administration route and ingredient, dosage form, and standard unit, similar to the drug code listed in the drug price standard. In the example of FIG. 7, the products containing "prednisolone" as an ingredient all have the same medicinal effect, the same route, the same ingredient, and the same standard. Therefore, "2456001F1" in the 0th to 8th digits (upper 9 digits) surrounded by the alternate long and short dash line in the individual drug code is, in principle, the same for these products.

On the other hand, the 9th to 11th digits of the individual drug code are codes assigned to each product. In the example of FIG. 7, the 9th to 11th digits of the individual drug code are "310" for the product name "prednisolone (registered trademark) tablet 5 mg" and "345" for the product name "prednisolone tablet 5 mg (company A)". The name "prednisolone tablet" Company T "5 mg" is "353".

As described above, it is guaranteed that drugs having the same upper 9-digit code have the same drug efficacy, the same route, the same ingredient, and the same standard in both the drug price standard listed drug code and the individual drug code.

By the way, when a new standard unit is created (newly established) for a certain drug, the drug of the new standard unit may be added to the standard master 21b. For example, for a certain drug, 5 mg standard units are added to the existing 10 mg and 20 mg standard units.

Drugs to which a standard unit has been added basically often have the same efficacy, the same route, and the same ingredients as the existing standard unit drug. Therefore, when a standard unit is added to a certain drug, if the drug is an excluded drug, the added standard unit drug is also likely to be an excluded drug. The same can be said for the dosage form as for the standard unit.

That is, in order to identify a drug having the same component (for example, the same drug efficacy, the same route, and the same component), the 7th to 8th digits (code C and code C) relating to the dosage form and standard unit among the upper 9 digits of the drug code. It can be said that the code of D) is unnecessary. In other words, drugs having the same code in the 0th to 6th digits (codes A and B), which are the upper 7 digits of the drug code, are guaranteed to have the same efficacy, the same route, and the same component.

Therefore, in one embodiment, the exclusion table management unit 23b sets the 0th to 6th digits (upper 7 digits) of the drug codes of the excluded drugs registered in the exclusion table 21c as the drug codes of the exclusion table 21c. To do.

The determination unit 23c may determine whether or not a drug having the same component as the drug (to be registered) to be registered in the in-hospital adopted drug master 21a is registered in the exclusion table 21c as an exclusion drug.

Further, in the determination unit 23c, the drug information (for example, information on the excluded drug) of the drug to be registered is the information on the drug of the drug registered in the exclusion table 21c or the standard set value master 21b according to the determination result. It may be determined whether they are different. For example, the determination unit 23c may instruct the screen control unit 24 to display an alert when the information regarding the excluded drug is different from each other.

The determination unit 23c and the screen control unit 24 are examples of output units that output screen information.

[1-3] Operation Example Hereinafter, an operation example of the above-mentioned drug information registration system 1 will be described with reference to a flowchart. 8 and 9 are flowcharts illustrating an operation example of the drug information registration system 1 according to the embodiment.

In the following description, as an example of a method for suppressing the occurrence of an error in setting information about excluded drugs in the drug information registration system 1, the process related to the management of the comprehensive classification set value of excluded drugs will be focused on.

Therefore, in the following description, the description of the registration process of information other than the comprehensive classification setting information among the drug information by the master management unit 23a may be omitted. For example, in response to the reception of the first registration instruction, the master management unit 23a receives the drug code of the first target drug and the drug code of the first target drug when the first target drug is not registered in the in-hospital adopted drug master 21a. Comprehensive classification setting information may be registered in the in-hospital drug master 21a. The information to be registered includes information other than the comprehensive classification setting information, for example, information exemplified in FIG. 2 such as the official name of the drug, and other drug information setting values (drug prices, etc., set values exemplified in FIG. 2). Information other than) and the like may be included.

The screen control unit 24 generates screen information of the in-hospital adopted drug master registration change screen 200 based on the access request received from the operation terminal 3 by the communication unit 22. The communication unit 22 transmits the screen information to the operation terminal 3. Based on the received screen information, the operation terminal 3 displays the in-hospital adopted drug master registration change screen 200 on the display device of the operation terminal 3 (step S1).

The communication unit 22 accepts the registration of the input value by receiving the access request including the input value which is the operation result of the in-hospital adopted drug master registration change screen 200, for example, the first registration instruction from the operation terminal 3 (step S2). .. The input value may include the drug code of the first target drug to be registered and the comprehensive classification setting information of the first target drug.

The determination unit 23c determines whether or not a drug having the same efficacy, administration route, and component as the drug to be registered is registered in the exclusion table 21c as an exclusion drug. The drug to be registered is a drug that the staff is trying to register in the in-hospital drug master 21a, and as an example, a drug indicated by the drug code entered in the setting area 230 (see FIG. 4).

For example, the determination unit 23c extracts the drug code from the input value received by the communication unit 22, and determines whether or not a record having the same key as the upper 7 digits of the extracted drug code exists in the exclusion table 21c (step). S3). For example, the determination unit 23c may search the drug code in the exclusion table 21c using the upper 7-digit code of the drug code as a key, and determine whether or not there is an entry (record) corresponding to the key.

When the entry corresponding to the key exists in the exclusion table 21c (YES in step S3), the drug to be registered has the same component as the drug registered in the exclusion table 21c (for example, the same efficacy, the same route of administration and the same component). It is highly possible that the drug has.

In this way, when the character string matching a part of the character string of the drug code of the first target drug is registered in the exclusion table 21c, the determination unit 23c registers the first target drug in the exclusion table 21c. It may be determined that it is. As a result, it is possible to collectively manage excluded drugs for drugs containing a common character string, for example, drugs having the same components and the like. Therefore, it is possible to reliably avoid the occurrence of omission of setting of excluded drugs among drugs having the same components and the like.

The determination unit 23c determines the set value of the drug to be registered (for example, the input value of each item in the setting area 240) and the set value of the entry (record) of the exclusion table 21c detected by the search (for example, the comprehensive classification set value). Compare (step S4).

Then, the determination unit 23c determines whether or not there are items having different values between the input value and the comprehensive classification setting value of the exclusion table 21c (step S5).

As a result of comparison, when there are no items having different values (NO in step S5), it can be said that the in-hospital adopted drug master 21a and the exclusion table 21c are properly maintained with respect to the drug exclusion setting. In this case, it is not necessary to change the exclusion table 21c regarding the excluded drug, and the process ends.

In addition, when the item having a different value does not exist, for example, when 5 mg standard unit is added to the conventionally existing 10 mg standard unit drug, the 10 mg standard unit drug existing in the exclusion table 21c This is the case when the value of the comprehensive category matches between the input value of the drug in the standard unit of 5 mg. In this case, the input value of the drug in the standard unit of 5 mg is in agreement with the comprehensive classification setting value of the drug in the standard unit of 10 mg. Therefore, it can be said that there is no error in setting the information regarding the excluded drug.

On the other hand, when items having different values exist (YES in step S5), the determination unit 23c may notify the screen control unit 24 of a warning (alert) display instruction.

In response to the reception of the warning display instruction, the screen control unit 24 displays screen information for displaying, for example, a pop-up screen 250 including a warning message on the in-hospital adopted drug master registration change screen 200, as illustrated in FIG. It may be generated (step S6). The screen information is an example of the second screen information indicating that the first target drug is an excluded drug.

In this way, the determination unit 23c includes the comprehensive classification setting information of the first target drug included in the first registration instruction and the comprehensive classification setting information of the excluded drug corresponding to the first target drug registered in the exclusion table 21c. If does not match, the screen information may include the display of an alert. As a result, for example, it is possible to prompt users such as hospital staff to confirm whether or not the first target drug is an excluded drug and whether or not the set value is correct, and it is possible to avoid omission of setting of the comprehensive classification setting. ..

On the pop-up screen 250, for example, among the values of the comprehensive classification (see FIGS. 2 and 5), the item names having different values, the comprehensive classification setting value of the item in the exclusion table 21c, and the input of the setting area 240 are input. The set value of the item of the value may be displayed.

In the example of FIG. 10, the setting value of the item of the specific hospitalization fee "A" in the comprehensive classification setting information of the drug of the drug code "12345467A9012" is "2" in the exclusion table 21c, and "0" in the input value. Indicates the case where. In this example, in the exclusion table 21c, a set value as an excluded drug is set in the item of the specific hospitalization fee “A”, but a set value as an excluded drug is not set in the input value.

11 and 12 are diagrams showing other examples of the setting contents of the in-hospital adopted drug master registration change screen 200 and the pop-up screen 250 shown in FIGS. 4 and 10. In the example of FIG. 11, among the input values of the comprehensive classification setting information, the value of the item of the specific hospitalization fee A is “9”. In the example of FIG. 12, the setting value of the item of the specific hospitalization fee “A” in the comprehensive classification setting information of the drug of the drug code “12345467A9012” is “2” in the exclusion table 21c, and “9” in the input value. Indicates the case where. In this example, for the item of the specific hospitalization fee "A", although the set value as the excluded drug is set in both the exclusion table 21c and the input value, the value is different.

The master management unit 23a may register the input value in the in-hospital adopted drug master 21a after the comparison in step S4. Further, when the master management unit 23a registers the comprehensive classification setting information in the in-hospital adopted drug master 21a in step S8 or S10 described later, the master management unit 23a registers the input values other than the comprehensive classification setting information in the in-hospital adopted drug master 21a. May be good.

The communication unit 22 is selected by the operation terminal 3 (staff) in response to the question "The value in the exclusion drug comprehensive setting table is different, but do you want to update it?" Displayed on the pop-up screen 250, for example. Receive an access request containing a "yes" or "no" operating instruction. The access request is an example of an instruction to update the exclusion table 21c or an instruction not to update the exclusion table 21c.

The determination unit 23c may determine whether or not the communication unit 22 has received an access request including a "yes" operation instruction. In other words, the determination unit 23c determines whether or not the communication unit 22 has received the update instruction of the exclusion table 21c (step S7).

When the update instruction of the exclusion table 21c (YES in step S7) is received (YES in step S7), the master management unit 23a sets the input value of the setting area 240 as positive and sets the comprehensive classification of the in-hospital drug master 21a. The value is updated according to the input value (step S8).

Further, the exclusion table management unit 23b updates the set value of the exclusion table 21c according to the set value of the in-hospital adopted drug master 21a, in other words, the input value of the setting area 240 (step S9), and the process ends. In other words, the exclusion table management unit 23b updates the comprehensive classification setting information of the first target drug registered in the exclusion table 21c by using the comprehensive classification setting information of the first target drug included in the first registration instruction. This is an example of the first update unit.

When the communication unit 22 receives the operation instruction of "Yes", for example, when there is an item with a setting error in the comprehensive classification setting information of the existing excluded drugs existing in the in-hospital adopted drug master 21a and the exclusion table 21c. Can be mentioned. As an example, the same drug as the excluded drug with a setting error, or another drug having the same component (for example, a drug to which another standard unit is added) is registered in the in-hospital adopted drug master 21a with the correct setting value. For example.

On the other hand, when the update instruction of the exclusion table 21c is not received (NO in step S7), the master management unit 23a treats the set value of the exclusion table 21c as positive. That is, the master management unit 23a updates the set value of the comprehensive classification setting information of the in-hospital adopted drug master 21a according to the set value of the exclusion table 21c (step S10), and the process ends. In other words, when the master management unit 23a receives an instruction not to update the exclusion table 21c, the master management unit 23a displays the comprehensive classification setting information of the excluded drug corresponding to the first target drug registered in the exclusion table 21c. This is an example of the second update unit that updates the comprehensive classification setting information of the first target drug registered in the in-hospital adopted drug master 21a.

When the communication unit 22 does not receive the update instruction of the exclusion table 21c, in other words, when it receives the operation instruction of "No", for example, there is an item having a setting error in the comprehensive classification setting information of the drug to be registered. There are cases where it exists. As an example, there is a case where a drug having the same setting value as an existing excluded drug or another drug having the same component and having a setting error is registered in the in-hospital adopted drug master 21a.

In either case of YES or NO in step S7, the staff member displays the pop-up screen 250 to make a setting error in the comprehensive classification setting information in at least one of the existing drug and the drug to be registered. You can notice that it exists. If the staff can be aware of the existence of a setting error, the staff can check the comprehensive classification setting information for at least one of the existing drug and the drug to be registered, and determine the correct setting value of the item having the setting error. For example, the staff selects "Yes" or "No" on the pop-up screen 250 via the operation terminal 3 according to the judgment result, thereby causing the operation terminal 3 to send an operation instruction to the server 2 and making a setting error. Can be corrected. In other words, the processing unit 23 can reliably update the exclusion table 21c or the in-hospital adopted drug master 21a in response to an instruction from the user.

Returning to the description of FIG. 8, in step S3, it is assumed that the entry corresponding to the upper 7-digit key of the drug code extracted from the input value does not exist in the exclusion table 21c (NO in step S3).

If the entry corresponding to the key does not exist in the exclusion table 21c, the drug to be registered is not an excluded drug (non-excluded drug, ordinary drug), or the drug to be registered is an excluded drug but has the same component. It is highly likely that other excluded drugs having the above are not registered in the exclusion table 21c.

Therefore, as shown in FIG. 9, the determination unit 23c identifies the record of the standard set value master 21b that matches the drug code of the drug to be registered (for example, the input value of the setting area 230) (step S11). Since the individual drug code and the drug code listed in the drug price standard may be the same, the determination unit 23c may specify (search) the record of the standard set value master 21b that matches the individual drug code in step S11. ..

Further, the determination unit 23c compares the input value of the drug to be registered (for example, each comprehensive category set value) with the set value (for example, each comprehensive category set value) of the entry (record) of the specified standard set value master 21b. (Step S12).

Then, the determination unit 23c determines whether or not there are items having different values between the input value and the set value of the standard set value master 21b (step S13). In other words, the determination unit 23c determines whether or not the comprehensive classification setting information included in the first registration instruction is different from the initial comprehensive classification setting information of the first target drug registered in the standard master 21b.

When there are no items having different values (NO in step S13), it is highly possible that the drug to be registered is not an excluded drug (a non-excluded drug). As shown in FIG. 5, a setting value other than "0" is set for any of the items in the comprehensive classification setting information of the excluded drug. On the other hand, as illustrated in FIG. 3, in the standard setting value master 21b provided by the vendor, "0" is set for all the items of the comprehensive classification setting information.

Drugs that are not excluded drugs for which all items of the comprehensive classification setting information are initial values (0) are not registered in the exclusion table 21c. Therefore, if there are no items with different values, the process ends.

On the other hand, when items having different values exist (YES in step S13), the drug to be registered is likely to be an excluded drug. In this case, the determination unit 23c may notify the screen control unit 24 of a warning (alert) display instruction.

In response to the reception of the warning display instruction, the screen control unit 24 displays screen information for displaying, for example, a pop-up screen 260 including a warning message on the in-hospital adopted drug master registration change screen 200, as illustrated in FIG. It may be generated (step S14).

On the pop-up screen 260, for example, the upper 7-digit drug code, the item having a different value from the comprehensive category values (see FIGS. 2 and 3), and the set value of the input value of the setting area 240 are displayed. , May be displayed. In the example of FIG. 13, the upper 7 digits of the drug code is "12345467", the specific hospitalization fee is "A", and the set value of the item of the specific hospitalization fee "A" in the exclusion table 21c is "9". Indicates a case. For example, in the pop-up screen 260 shown in FIG. 13, the exclusion table 21c uses an entry (record) in which the setting value of the item of the specific hospitalization fee “A” is “9” and the upper 7 digits “1234567” of the drug code as a key. It is a screen to confirm whether or not to newly register in. In addition, the pop-up screen 260 may display an inquiry asking "Do you want to newly register in the exclusion drug comprehensive setting table?".

The screen information including the pop-up screen 260 is an example of the first screen information for inquiring whether or not to register the first target drug in the exclusion table 21c.

Further, the determination unit 23c and the screen control unit 24 refer to the memory unit 21 in response to the reception of the first registration instruction, and the comprehensive classification setting information included in the first registration instruction is the initial comprehensive classification of the first target drug. This is an example of an output unit that outputs the first screen information when it is different from the setting information.

In the determination unit 23c and the screen control unit 24, when the first target drug is not registered in the exclusion table 21c, the comprehensive classification setting information of the first target drug is registered in the standard master 21b as the first target. The first screen information may be output when it is different from the initial comprehensive classification setting information of the drug. As a result, the first target drug whose comprehensive category setting value corresponds to the excluded drug can be reliably detected.

The master management unit 23a may register the input value in the in-hospital adopted drug master 21a after the comparison in step S12. In other words, the master management unit 23a responds to the receipt of the first registration instruction, and when the first target drug is not registered in the in-hospital adopted drug master 21a, the master management unit 23a sets the drug code of the first target drug and the first target. The comprehensive classification setting information of the drug may be registered in the in-hospital drug master 21a.

The communication unit 22 receives, for example, an access request including a “yes” or “no” operation instruction selected by the operation terminal 3 (staff) for the question displayed on the pop-up screen 260.

The determination unit 23c may determine whether or not the communication unit 22 has received an access request including a "yes" operation instruction. In other words, the determination unit 23c determines whether or not the communication unit 22 has received the registration instruction to the exclusion table 21c (step S15).

When the registration instruction to the exclusion table 21c (operation instruction of "Yes") is received (YES in step S15), the exclusion table management unit 23b uses the upper 7 digits of the drug code among the input values as a key to the exclusion table. A record is created in 21c (step S16).

Further, the exclusion table management unit 23b stores the value of the comprehensive classification in the record registered in the in-hospital drug master 21a by the master management unit 23a in the set value of the record of the exclusion table 21c created in step S16 (step S17). , The process ends. In other words, when the exclusion table management unit 23b receives the second registration instruction instructing the registration of the first target drug in the exclusion table 21c, the exclusion table management unit 23b registers the first target drug in the exclusion table 21c.

When the communication unit 22 receives the operation instruction of "Yes", for example, the drug information of the excluded drug not registered in the in-hospital adopted drug master 21a and the exclusion table 21c is newly added to the in-hospital adopted drug master 21a and the exclusion table 21c. There is a case of registering in.

On the other hand, when the registration instruction to the exclusion table 21c has not been received (the operation instruction of "No" has been received) (NO in step S15), the process ends.

The communication unit 22 does not receive the registration instruction in the exclusion table 21c, in other words, receives the operation instruction of "No". In some cases, for example, an item having a setting error in the comprehensive classification setting information of the drug to be registered. May exist. As an example, there is a case where an employee tries to register a drug that is not an excluded drug in the in-hospital adopted drug master 21a as an excluded drug.

If NO in step S15, the staff can notice that there is a setting error in the comprehensive classification setting information in the drug information of the drug to be registered by displaying the pop-up screen 260. If the staff can be aware of the existence of the setting error, the staff can confirm the comprehensive classification setting information of the drug to be registered and determine the correct setting value of the item having the setting error. For example, the staff can make the operation terminal 3 transmit the operation instruction to the server 2 by selecting "No" on the pop-up screen 260 via the operation terminal 3 according to the determination result.

Therefore, if NO in step S15, the master management unit 23a may discard the input value of the in-hospital adopted drug master registration change screen 200 and suppress the registration process of the input value for the in-hospital adopted drug master 21a. In other words, the master management unit 23a may end the process.

As described above, the drug information registration process for the in-hospital adopted drug master 21a and the exclusion table 21c by the drug information registration system 1 according to the embodiment is completed.

As described above, according to the drug information registration system 1 according to the embodiment, it is easy to judge whether or not the drug is excluded even if the hospital staff does not have medical and pharmaceutical knowledge, and quickly and. , You can surely make the correct settings. This makes it possible to prevent omission of calculation for excluded drugs. Therefore, medical institutions and the like can earn income in accordance with the medical fee system without omission. Further, since the drug information registration system 1 according to one embodiment can be used to determine whether or not the target drug to be registered is an excluded drug at the time of registration and renewal of the in-hospital adopted drug master 21a, medical accounting has already been performed. It can also be applied to medical institutions where the system is operating.

For example, the determination unit 23c and the screen control unit 24 refer to the memory unit 21 that stores the exclusion table 21c in response to the reception of the first registration instruction including the comprehensive classification setting information of the first target drug, and perform the first registration. When the comprehensive classification setting information included in the instruction is different from the initial comprehensive classification setting information of the first target drug, the first screen information for displaying the pop-up screen 260 may be output. Further, when the exclusion table management unit 23b receives the second registration instruction instructing the registration of the first target drug in the exclusion table 21c, the exclusion table management unit 23b may register the first target drug in the exclusion table 21c. As a result, the first target drug that is not registered in the exclusion table 21c can be reliably registered in the exclusion table 21c as an exclusion drug.

[1-4] Hardware Configuration Example FIG. 14 is a block diagram showing a hardware (HW) configuration example of the computer 10 that realizes the function of the server 2. When a plurality of computers are used as the HW resource that realizes the function of the server 2, each computer may have the HW configuration illustrated in FIG.

As shown in FIG. 14, the computer 10 has an HW configuration, for example, a processor 10a, a memory 10b, a storage unit 10c, an IF (Interface) unit 10d, an I / O (Input / Output) unit 10e, and a reading unit. It may be provided with 10f.

The processor 10a is an example of an arithmetic processing unit that performs various controls and operations. The processor 10a may be connected to each block in the computer 10 so as to be able to communicate with each other by the bus 10i. The processor 10a may be a multiprocessor including a plurality of processors, a multicore processor having a plurality of processor cores, or a configuration having a plurality of multicore processors.

Examples of the processor 10a include integrated circuits (ICs) such as CPUs, MPUs, GPUs, APUs, DSPs, ASICs, and FPGAs. A combination of two or more of these integrated circuits may be used as the processor 10a. CPU is an abbreviation for Central Processing Unit, and MPU is an abbreviation for Micro Processing Unit. GPU is an abbreviation for Graphics Processing Unit, and APU is an abbreviation for Accelerated Processing Unit. DSP is an abbreviation for Digital Signal Processor, ASIC is an abbreviation for Application Specific IC, and FPGA is an abbreviation for Field-Programmable Gate Array.

The memory 10b is an example of an HW that stores information such as various data and programs. Examples of the memory 10b include one or both of a volatile memory such as DRAM (Dynamic Random Access Memory) and a non-volatile memory such as PM (Persistent Memory).

The storage unit 10c is an example of an HW that stores information such as various data and programs. Examples of the storage unit 10c include a magnetic disk device such as an HDD (Hard Disk Drive), a semiconductor drive device such as an SSD (Solid State Drive), and various storage devices such as a non-volatile memory. Examples of the non-volatile memory include flash memory, SCM (Storage Class Memory), ROM (Read Only Memory) and the like.

Further, the storage unit 10c may store a program 10g (drug information registration support program) that realizes all or a part of various functions of the computer 10. For example, the processor 10a of the server 2 can realize the function as the server 2 illustrated in FIG. 1 by expanding and executing the program 10g stored in the storage unit 10c in the memory 10b.

The in-hospital adopted drug master 21a, the standard set value master 21b, and the excluded drug comprehensive setting table 21c shown in FIG. 1 may be stored in the storage area of at least one of the memory 10b and the storage unit 10c. In other words, the memory unit 21 shown in FIG. 1 may be realized by a storage area included in at least one of the memory 10b and the storage unit 10c.

The IF unit 10d is an example of a communication IF that controls connection with a network and communication. For example, the IF unit 10d may include an adapter compliant with LAN (Local Area Network) such as Ethernet (registered trademark) or optical communication such as FC (Fibre Channel). The adapter may support one or both wireless and wired communication methods. For example, the server 2 may be connected to the operation terminal 3 via the IF unit 10d so as to be able to communicate with each other. Further, for example, the program 10g may be downloaded from the network to the computer 10 via the communication IF and stored in the storage unit 10c.

The I / O unit 10e may include one or both of an input device and an output device. Examples of the input device include a keyboard, a mouse, a touch panel, and the like. Examples of the output device include a monitor, a projector, a printer and the like.

The reading unit 10f is an example of a reader that reads data and program information recorded on the recording medium 10h. The reading unit 10f may include a connection terminal or device to which the recording medium 10h can be connected or inserted. Examples of the reading unit 10f include an adapter compliant with USB (Universal Serial Bus) and the like, a drive device for accessing a recording disk, a card reader for accessing a flash memory such as an SD card, and the like. The program 10g may be stored in the recording medium 10h, or the reading unit 10f may read the program 10g from the recording medium 10h and store it in the storage unit 10c.

Examples of the recording medium 10h include a non-temporary computer-readable recording medium such as a magnetic / optical disk or a flash memory. Examples of magnetic / optical disks include flexible discs, CDs (Compact Discs), DVDs (Digital Versatile Discs), Blu-ray discs, HVDs (Holographic Versatile Discs), and the like. Examples of the flash memory include semiconductor memories such as USB memory and SD card.

The HW configuration of the computer 10 described above is an example. Therefore, the increase / decrease of HW (for example, addition or deletion of arbitrary blocks), division, integration in any combination, addition or deletion of buses, etc. in the computer 10 may be performed as appropriate. For example, in the server 2, at least one of the I / O unit 10e and the reading unit 10f may be omitted.

The operation terminal 3, which is an example of the information processing terminal, may be realized by the same HW configuration as the computer 10 described above.

For example, the processor 10a of the operation terminal 3 can realize the function as the operation terminal 3 shown in FIG. 1 by expanding and executing the program 10g stored in the storage unit 10c in the memory 10b.

The operation terminal 3 shown in FIG. 1 may include an input device and a display device, which are examples of the I / O unit 10e. For example, the processor 10a of the operation terminal 3 may display the in-hospital adopted drug master registration change screen 200 shown in FIGS. 4 and 10 to 13 on the display device based on the information received from the server 2 via the IF10d. Further, the processor 10a of the operation terminal 3 may transmit the information input by the staff via the input device to the server 2 via the IF10d.

[2] Others The technology according to the above-described embodiment can be modified or modified as follows.

For example, the communication unit 22, the processing unit 23 (master management unit 23a, exclusion table management unit 23b, and determination unit 23c) included in the server 2 shown in FIG. 1 and the screen control unit 24 may be merged in any combination. Well, each may be divided.

Further, the server 2 shown in FIG. 1 may have a configuration in which a plurality of devices cooperate with each other via a network to realize each processing function. As an example, the communication unit 22 and the screen control unit 24 may be a Web server, the processing unit 23 may be an application server, and the memory unit 21 may be a DB server. In this case, the Web server, the application server, and the DB server may realize each processing function as the server 2 by cooperating with each other via the network.

Further, in one embodiment, it has been described that one or both of the drug price standard listed drug code and the individual drug code are used as the drug code. Then, in one embodiment, it has been described that the upper 7-digit code of the drug code is registered as a key in the exclusion table 21c. However, the method according to one embodiment is not limited to this, and various codes that systematically indicate the drug efficacy, administration route, ingredients, etc. may be used as the drug code.

For example, as the drug code, a code that is associated with the master of the medical accounting system (for example, the in-hospital adopted drug master 21a) and the associated code is used in the medical accounting process may be used.

[3] Additional Notes The following additional notes will be further disclosed with respect to the above embodiments.

(Appendix 1)
In response to the receipt of the first registration instruction containing the setting information including the setting values related to the comprehensive processing of the first target drug subject to the medical accounting treatment, the comprehensive processing during the medical accounting processing When the setting information included in the first registration instruction is different from the initial setting information of the first target drug by referring to the storage area for storing the exclusion drug database in which information on the excluded drug is registered. , Outputs the first screen information inquiring whether or not to register the first target drug in the excluded drug database.
When the second registration instruction instructing the registration of the first target drug in the exclusion drug database is received, the first target drug is registered in the exclusion drug database.
A drug information registration support program that allows a computer to perform processing.

(Appendix 2)
The storage area is a reference drug database in which identification information of a target drug subject to the medical accounting process and initial setting information including initial values related to comprehensive processing of the target drug during the medical accounting process are registered. Remember,
The output of the first screen information is when the first target drug is not registered in the excluded drug database, and the setting information of the first target drug is registered in the reference drug database. 1 Output the first screen information when it is different from the initial setting information of the target drug.
The drug information registration support program described in Appendix 1.

(Appendix 3)
The storage area stores a drug database in which identification information of a target drug subject to the medical accounting process and setting information including setting values related to comprehensive processing of the target drug during the medical accounting process are registered. And
Among the target drugs registered in the drug database, the excluded drugs that are not subject to the comprehensive processing at the time of the medical accounting process are registered in the excluded drug database.
On the computer
In response to the receipt of the first registration instruction including the identification information of the first target drug, when the first target drug is not registered in the drug database, the identification information of the first target drug and the first target drug. 1 Register the setting information of the target drug in the drug database.
The drug information registration support program described in Appendix 1 or Appendix 2 that executes the process.

(Appendix 4)
In the exclusion drug database, a character string of a part of the identification information of the exclusion drug is registered.
The first registration instruction includes identification information of the first target drug.
On the computer
When a character string matching a part of the character string of the identification information of the first target drug is registered in the exclusion drug database, it is determined that the first target drug is registered in the exclusion drug database. ,
The drug information registration support program according to any one of Supplementary note 1 to Supplementary note 3, which executes the process.

(Appendix 5)
On the computer
When the first target drug is registered in the exclusion drug database, a second screen information indicating that the first target drug is an exclusion drug is output.
The drug information registration support program described in Appendix 4 that executes the process.

(Appendix 6)
In the exclusion drug database, setting information including setting values related to comprehensive processing at the time of the medical accounting processing of the exclusion drug is registered.
On the computer
When the first target drug is registered in the exclusion drug database, the setting information of the first target drug included in the first registration instruction and the first target drug registered in the exclusion drug database. If the setting information of the excluded drug corresponding to the target drug does not match, the display of the alert is included in the second screen information.
The drug information registration support program described in Appendix 5 that executes the process.

(Appendix 7)
On the computer
When an instruction to update the exclusion drug database is received, the first target drug registered in the exclusion drug database is used by using the setting information of the first target drug included in the first registration instruction. Update the setting information of
The drug information registration support program described in Appendix 6 that executes the process.

(Appendix 8)
The storage area stores a drug database in which identification information of a target drug subject to the medical accounting process and setting information including setting values related to comprehensive processing of the target drug during the medical accounting process are registered. And
On the computer
When an instruction not to update the exclusion drug database is received, the exclusion drug setting information corresponding to the first target drug registered in the exclusion drug database is used to be registered in the drug database. Update the setting information of the first target drug,
The drug information registration support program according to Appendix 6 or Appendix 7, which executes the process.

(Appendix 9)
In response to the receipt of the registration instruction including the identification information of the first target drug subject to the medical accounting process and the setting information including the setting value related to the comprehensive processing of the first target drug at the time of the medical accounting process. A drug database in which identification information of a target drug subject to medical accounting processing and setting information including setting values related to the comprehensive processing of the target drug are registered, identification information of the target drug, and the target drug of the target drug. A reference drug database in which initial setting information including initial values related to the comprehensive processing is registered, a part of character strings of identification information of excluded drugs that are not subject to the comprehensive processing, and the comprehensive processing of the excluded drugs. Refer to the storage area that stores the setting information including the setting value for, the exclusion drug database in which is registered, and
When the identification information of the first target drug is registered in the exclusion drug database and the setting information of the first target drug is different from the setting information of the exclusion drug database, the setting information of the exclusion drug database is used. Output screen information including an alert inquiring whether to update,
When the identification information of the first target drug is registered in the exclusion drug database and the setting information of the first target drug matches the setting information of the exclusion drug database, the process is terminated.
When the identification information of the first target drug is not registered in the exclusion drug database and the setting information of the first target drug matches the initial setting information of the reference drug database, the first target drug is selected. Register in the drug database
When the identification information of the first target drug is not registered in the exclusion drug database and the setting information of the first target drug is different from the initial setting information of the reference drug database, the first target drug is stored in the exclusion drug database. 1 Output screen information including an alert inquiring whether to register the target drug,
A drug information registration support program that allows a computer to perform processing.

(Appendix 10)
A storage area that stores an exclusion drug database in which information about excluded drugs that are not subject to comprehensive processing during medical accounting processing is registered,
In response to the reception of the first registration instruction including the setting information including the setting value related to the comprehensive processing at the time of the medical accounting processing of the first target drug subject to the medical accounting processing, the storage area is referred to. When the setting information included in the first registration instruction is different from the initial setting information of the first target drug, the first screen information for inquiring whether to register the first target drug in the excluded drug database is output. Output section and
Upon receiving the second registration instruction instructing the first target drug to be registered in the exclusion drug database, the first registration unit for registering the first target drug in the exclusion drug database, and the first registration unit.
A drug information registration support system equipped with.

(Appendix 11)
The storage area is a reference drug database in which identification information of a target drug subject to the medical accounting process and initial setting information including initial values related to comprehensive processing of the target drug during the medical accounting process are registered. Remember,
The output unit is a case where the first target drug is not registered in the excluded drug database, and the setting information of the first target drug is the setting information of the first target drug registered in the reference drug database. If it is different from the initial setting information, the first screen information is output.
The drug information registration support system described in Appendix 10.

(Appendix 12)
The storage area stores a drug database in which identification information of a target drug subject to the medical accounting process and setting information including setting values related to comprehensive processing of the target drug during the medical accounting process are registered. And
Among the target drugs registered in the drug database, the excluded drugs that are not subject to the comprehensive processing at the time of the medical accounting process are registered in the excluded drug database.
In response to the receipt of the first registration instruction including the identification information of the first target drug, when the first target drug is not registered in the drug database, the identification information of the first target drug and the first target drug. (1) A second registration unit for registering the setting information of the target drug in the drug database is provided.
The drug information registration support system according to Appendix 10 or Appendix 11.

(Appendix 13)
In the exclusion drug database, a character string of a part of the identification information of the exclusion drug is registered.
The first registration instruction includes identification information of the first target drug, and includes the identification information of the first target drug.
In the output unit, when a character string matching a part of the character string of the identification information of the first target drug is registered in the exclusion drug database, the first target drug is registered in the exclusion drug database. Judge that
The drug information registration support system according to any one of Supplementary note 10 to Supplementary note 12.

(Appendix 14)
When the first target drug is registered in the exclusion drug database, the output unit outputs second screen information indicating that the first target drug is an exclusion drug.
The drug information registration support system described in Appendix 13.

(Appendix 15)
In the exclusion drug database, setting information including setting values related to comprehensive processing at the time of the medical accounting processing of the exclusion drug is registered.
The output unit is a case where the first target drug is registered in the exclusion drug database, and is registered in the exclusion drug database and the setting information of the first target drug included in the first registration instruction. When the setting information of the excluded drug corresponding to the first target drug does not match, the display of the alert is included in the second screen information.
The drug information registration support system described in Appendix 14.

(Appendix 16)
When an instruction to update the exclusion drug database is received, the first target drug registered in the exclusion drug database is used by using the setting information of the first target drug included in the first registration instruction. The first update part, which updates the setting information of
The drug information registration support system described in Appendix 15.

(Appendix 17)
The storage area stores a drug database in which identification information of a target drug subject to the medical accounting process and setting information including setting values related to comprehensive processing of the target drug during the medical accounting process are registered. And
When an instruction not to update the exclusion drug database is received, the exclusion drug setting information corresponding to the first target drug registered in the exclusion drug database is used, and the drug is registered in the drug database. A second update unit, which updates the setting information of the first target drug, is provided.
The drug information registration support system according to Appendix 15 or Appendix 16.

(Appendix 18)
In response to the receipt of the first registration instruction containing the setting information including the setting values related to the comprehensive processing of the first target drug subject to the medical accounting treatment, the comprehensive processing during the medical accounting processing When the setting information included in the first registration instruction is different from the initial setting information of the first target drug by referring to the storage area for storing the exclusion drug database in which information on the excluded drug is registered. , Outputs the first screen information inquiring whether or not to register the first target drug in the excluded drug database.
When the second registration instruction instructing the registration of the first target drug in the exclusion drug database is received, the first target drug is registered in the exclusion drug database.
A drug information registration support method in which a computer executes processing.

(Appendix 19)
The storage area is a reference drug database in which identification information of a target drug subject to the medical accounting process and initial setting information including initial values related to comprehensive processing of the target drug during the medical accounting process are registered. Remember,
The output of the first screen information is when the first target drug is not registered in the excluded drug database, and the setting information of the first target drug is registered in the reference drug database. 1 Output the first screen information when it is different from the initial setting information of the target drug.
The drug information registration support method described in Appendix 18.

(Appendix 20)
In response to the receipt of the registration instruction including the identification information of the first target drug subject to the medical accounting process and the setting information including the setting value related to the comprehensive processing of the first target drug at the time of the medical accounting process. A drug database in which identification information of a target drug subject to medical accounting processing and setting information including setting values related to the comprehensive processing of the target drug are registered, identification information of the target drug, and the target drug of the target drug. A reference drug database in which initial setting information including initial values related to the comprehensive processing is registered, a part of character strings of identification information of excluded drugs that are not subject to the comprehensive processing, and the comprehensive processing of the excluded drugs. Refer to the storage area that stores the setting information including the setting value for, the exclusion drug database in which is registered, and
When the identification information of the first target drug is registered in the exclusion drug database and the setting information of the first target drug is different from the setting information of the exclusion drug database, the setting information of the exclusion drug database is used. Output screen information including an alert inquiring whether to update,
When the identification information of the first target drug is registered in the exclusion drug database and the setting information of the first target drug matches the setting information of the exclusion drug database, the process is terminated.
When the identification information of the first target drug is not registered in the exclusion drug database and the setting information of the first target drug matches the initial setting information of the reference drug database, the first target drug is selected. Register in the drug database
When the identification information of the first target drug is not registered in the exclusion drug database and the setting information of the first target drug is different from the initial setting information of the reference drug database, the first target drug is stored in the exclusion drug database. 1 Output screen information including an alert inquiring whether to register the target drug,
A drug information registration support method in which a computer executes processing.

1 Drug information registration system 10 Computer 2 Server 21 Memory unit 21a In-hospital drug master 21b Standard setting value master 21c Excluded drug comprehensive setting table 22 Communication unit 23 Processing unit 23a Master management unit 23b Exclusion table management unit 23c Judgment unit 24 Screen control unit 3 Operation terminal

Claims (11)

In response to the receipt of the first registration instruction containing the setting information including the setting values related to the comprehensive processing of the first target drug subject to the medical accounting treatment, the comprehensive processing during the medical accounting processing When the setting information included in the first registration instruction is different from the initial setting information of the first target drug by referring to the storage area for storing the exclusion drug database in which information on the excluded drug is registered. , Outputs the first screen information inquiring whether or not to register the first target drug in the excluded drug database.
When the second registration instruction instructing the registration of the first target drug in the exclusion drug database is received, the first target drug is registered in the exclusion drug database.
A drug information registration support program that allows a computer to perform processing. The storage area is a reference drug database in which identification information of a target drug subject to the medical accounting process and initial setting information including initial values related to comprehensive processing of the target drug during the medical accounting process are registered. Remember,
The output of the first screen information is when the first target drug is not registered in the excluded drug database, and the setting information of the first target drug is registered in the reference drug database. 1 Output the first screen information when it is different from the initial setting information of the target drug.
The drug information registration support program according to claim 1. The storage area stores a drug database in which identification information of a target drug subject to the medical accounting process and setting information including setting values related to comprehensive processing of the target drug during the medical accounting process are registered. And
Among the target drugs registered in the drug database, the excluded drugs that are not subject to the comprehensive processing at the time of the medical accounting process are registered in the excluded drug database.
On the computer
In response to the receipt of the first registration instruction including the identification information of the first target drug, when the first target drug is not registered in the drug database, the identification information of the first target drug and the first target drug. 1 Register the setting information of the target drug in the drug database.
The drug information registration support program according to claim 1 or 2, wherein the process is executed. In the exclusion drug database, a character string of a part of the identification information of the exclusion drug is registered.
The first registration instruction includes identification information of the first target drug.
On the computer
When a character string matching a part of the character string of the identification information of the first target drug is registered in the exclusion drug database, it is determined that the first target drug is registered in the exclusion drug database. ,
The drug information registration support program according to any one of claims 1 to 3, wherein the process is executed. On the computer
When the first target drug is registered in the exclusion drug database, a second screen information indicating that the first target drug is an exclusion drug is output.
The drug information registration support program according to claim 4, wherein the processing is executed. In the exclusion drug database, setting information including setting values related to comprehensive processing at the time of the medical accounting processing of the exclusion drug is registered.
On the computer
When the first target drug is registered in the exclusion drug database, the setting information of the first target drug included in the first registration instruction and the first target drug registered in the exclusion drug database. If the setting information of the excluded drug corresponding to the target drug does not match, the display of the alert is included in the second screen information.
The drug information registration support program according to claim 5, which executes the process. On the computer
When an instruction to update the exclusion drug database is received, the first target drug registered in the exclusion drug database is used by using the setting information of the first target drug included in the first registration instruction. Update the setting information of
The drug information registration support program according to claim 6, wherein the processing is executed. The storage area stores a drug database in which identification information of a target drug subject to the medical accounting process and setting information including setting values related to comprehensive processing of the target drug during the medical accounting process are registered. And
On the computer
When an instruction not to update the exclusion drug database is received, the exclusion drug setting information corresponding to the first target drug registered in the exclusion drug database is used to be registered in the drug database. Update the setting information of the first target drug,
The drug information registration support program according to claim 6 or 7, wherein the process is executed. In response to the receipt of the registration instruction including the identification information of the first target drug subject to the medical accounting process and the setting information including the setting value related to the comprehensive processing of the first target drug at the time of the medical accounting process. A drug database in which identification information of a target drug subject to medical accounting processing and setting information including setting values related to the comprehensive processing of the target drug are registered, identification information of the target drug, and the target drug of the target drug. A reference drug database in which initial setting information including initial values related to the comprehensive processing is registered, a part of character strings of identification information of excluded drugs that are not subject to the comprehensive processing, and the comprehensive processing of the excluded drugs. Refer to the storage area that stores the setting information including the setting value for, the exclusion drug database in which is registered, and
When the identification information of the first target drug is registered in the exclusion drug database and the setting information of the first target drug is different from the setting information of the exclusion drug database, the setting information of the exclusion drug database is used. Output screen information including an alert inquiring whether to update,
When the identification information of the first target drug is registered in the exclusion drug database and the setting information of the first target drug matches the setting information of the exclusion drug database, the process is terminated.
When the identification information of the first target drug is not registered in the exclusion drug database and the setting information of the first target drug matches the initial setting information of the reference drug database, the first target drug is selected. Register in the drug database
When the identification information of the first target drug is not registered in the exclusion drug database and the setting information of the first target drug is different from the initial setting information of the reference drug database, the first target drug is stored in the exclusion drug database. 1 Output screen information including an alert inquiring whether to register the target drug,
A drug information registration support program that allows a computer to perform processing. A storage area that stores an exclusion drug database in which information about excluded drugs that are not subject to comprehensive processing during medical accounting processing is registered,
In response to the reception of the first registration instruction including the setting information including the setting value related to the comprehensive processing at the time of the medical accounting processing of the first target drug subject to the medical accounting processing, the storage area is referred to. When the setting information included in the first registration instruction is different from the initial setting information of the first target drug, the first screen information for inquiring whether to register the first target drug in the excluded drug database is output. Output section and
Upon receiving the second registration instruction instructing the first target drug to be registered in the exclusion drug database, the first registration unit for registering the first target drug in the exclusion drug database, and the first registration unit.
A drug information registration support system equipped with. In response to the receipt of the first registration instruction containing the setting information including the setting values related to the comprehensive processing of the first target drug subject to the medical accounting treatment, the comprehensive processing during the medical accounting processing When the setting information included in the first registration instruction is different from the initial setting information of the first target drug by referring to the storage area for storing the exclusion drug database in which information on the excluded drug is registered. , Outputs the first screen information inquiring whether or not to register the first target drug in the excluded drug database.
When the second registration instruction instructing the registration of the first target drug in the exclusion drug database is received, the first target drug is registered in the exclusion drug database.
A drug information registration support method in which a computer executes processing.

Images